164 related articles for article (PubMed ID: 22229645)
1. Topical application of disodium isostearyl 2-O-L-ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats.
Okubo K; Nakanishi H; Matsunami M; Shibayama H; Kawabata A
Br J Pharmacol; 2012 Jun; 166(3):1058-68. PubMed ID: 22229645
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Takahashi T; Aoki Y; Okubo K; Maeda Y; Sekiguchi F; Mitani K; Nishikawa H; Kawabata A
Pain; 2010 Jul; 150(1):183-191. PubMed ID: 20546998
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats.
Okubo K; Takahashi T; Sekiguchi F; Kanaoka D; Matsunami M; Ohkubo T; Yamazaki J; Fukushima N; Yoshida S; Kawabata A
Neuroscience; 2011 Aug; 188():148-56. PubMed ID: 21596106
[TBL] [Abstract][Full Text] [Related]
4. Permeation and metabolism of a novel ascorbic acid derivative, disodium isostearyl 2-O-L-ascorbyl phosphate, in human living skin equivalent models.
Shibayama H; Hisama M; Matsuda S; Ohtsuki M
Skin Pharmacol Physiol; 2008; 21(4):235-43. PubMed ID: 18552525
[TBL] [Abstract][Full Text] [Related]
5. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain.
Sekiguchi F; Kawara Y; Tsubota M; Kawakami E; Ozaki T; Kawaishi Y; Tomita S; Kanaoka D; Yoshida S; Ohkubo T; Kawabata A
Pain; 2016 Aug; 157(8):1655-1665. PubMed ID: 27023424
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate on melanogenesis.
Matsuda S; Shibayama H; Hisama M; Ohtsuki M; Iwaki M
Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):292-7. PubMed ID: 18310938
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.
Okubo K; Matsumura M; Kawaishi Y; Aoki Y; Matsunami M; Okawa Y; Sekiguchi F; Kawabata A
Br J Pharmacol; 2012 Jul; 166(5):1738-43. PubMed ID: 22300342
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate on human dermal fibroblasts: increased collagen synthesis and inhibition of MMP-1.
Shibayama H; Hisama M; Matsuda S; Ohtsuki M; Iwaki M
Biol Pharm Bull; 2008 Apr; 31(4):563-8. PubMed ID: 18379041
[TBL] [Abstract][Full Text] [Related]
10. Effect of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate, on normal human dermal fibroblasts against reactive oxygen species.
Shibayama H; Hisama M; Matsuda S; Kawase A; Ohtsuki M; Hanada K; Iwaki M
Biosci Biotechnol Biochem; 2008 Apr; 72(4):1015-22. PubMed ID: 18391439
[TBL] [Abstract][Full Text] [Related]
11. N- and L-type calcium channels blocker cilnidipine ameliorates neuropathic pain.
Yamamoto S; Suzuki Y; Ono H; Kume K; Ohsawa M
Eur J Pharmacol; 2016 Dec; 793():66-75. PubMed ID: 27823932
[TBL] [Abstract][Full Text] [Related]
12. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
13. Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice.
Sekiguchi F; Fujita T; Deguchi T; Yamaoka S; Tomochika K; Tsubota M; Ono S; Horaguchi Y; Ichii M; Ichikawa M; Ueno Y; Koike N; Tanino T; Nguyen HD; Okada T; Nishikawa H; Yoshida S; Ohkubo T; Toyooka N; Murata K; Matsuda H; Kawabata A
Neuropharmacology; 2018 Aug; 138():232-244. PubMed ID: 29913186
[TBL] [Abstract][Full Text] [Related]
14. Antimutagenic activity of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate.
Hisama M; Matsuda S; Shibayama H; Iwaki M
Yakugaku Zasshi; 2008 Jun; 128(6):933-40. PubMed ID: 18520139
[TBL] [Abstract][Full Text] [Related]
15. Effects of natural and synthetic isothiocyanate-based H
Di Cesare Mannelli L; Lucarini E; Micheli L; Mosca I; Ambrosino P; Soldovieri MV; Martelli A; Testai L; Taglialatela M; Calderone V; Ghelardini C
Neuropharmacology; 2017 Jul; 121():49-59. PubMed ID: 28431970
[TBL] [Abstract][Full Text] [Related]
16. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
17. Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain.
Chen SR; Cai YQ; Pan HL
J Neurochem; 2009 Jul; 110(1):352-62. PubMed ID: 19457113
[TBL] [Abstract][Full Text] [Related]
18. Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia.
Todorovic SM; Meyenburg A; Jevtovic-Todorovic V
Pain; 2004 Jun; 109(3):328-339. PubMed ID: 15157694
[TBL] [Abstract][Full Text] [Related]
19. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
Elmore AR
Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
[TBL] [Abstract][Full Text] [Related]
20. Dietary ascorbic acid restriction in GNL/SMP30-knockout mice unveils the role of ascorbic acid in regulation of somatic and visceral pain sensitivity.
Tsubota M; Uebo K; Miki K; Sekiguchi F; Ishigami A; Kawabata A
Biochem Biophys Res Commun; 2019 Apr; 511(3):705-710. PubMed ID: 30827506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
